Population pharmacokinetics analysis of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation.

about

Population pharmacokinetics analysis of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation.

Item

http://www.wikidata.org/entity/Q50924228

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Population pharmacokinetics an ...... tic stem cell transplantation.

@en

Population pharmacokinetics an ...... tic stem cell transplantation.

@nl

type

Item

label

Population pharmacokinetics an ...... tic stem cell transplantation.

@en

Population pharmacokinetics an ...... tic stem cell transplantation.

@nl

prefLabel

Population pharmacokinetics an ...... tic stem cell transplantation.

@en

Population pharmacokinetics an ...... tic stem cell transplantation.

@nl

P1476

Population pharmacokinetics an ...... tic stem cell transplantation.

@en

P2093

Helin Xie

http://www.w3.org/2001/XMLSchema#string

Jinhua Ren

http://www.w3.org/2001/XMLSchema#string

Nainong Li

http://www.w3.org/2001/XMLSchema#string

Shanshan Lin

http://www.w3.org/2001/XMLSchema#string

Ting Yang

http://www.w3.org/2001/XMLSchema#string

Weiwei Lin

http://www.w3.org/2001/XMLSchema#string

Xian Huang

http://www.w3.org/2001/XMLSchema#string

Xiaofan Li

http://www.w3.org/2001/XMLSchema#string

Xiaohong Yuan

http://www.w3.org/2001/XMLSchema#string

Xuemei Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of creatinine clearance from serum creatinine

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia.

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103).

Evaluating performance of a decision support system to improve methotrexate pharmacotherapy in children and young adults with cancer.

Glutathione S-transferase A1 genetic variants reduce busulfan clearance in children undergoing hematopoietic cell transplantation.

A simple dosing scheme for intravenous busulfan based on retrospective population pharmacokinetic analysis in korean patients

Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapy.

Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation.

Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipients

P304

529-538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1440-1681.12735

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28135768

http://www.w3.org/2001/XMLSchema#string